Browse the evidence

Dysfunctional adipose tissue, particularly visceral fat, drives CKM syndrome by secreting proinflammatory and prooxidative products that damage arterial, cardiac, and kidney tissues, leading to insulin resistance and systemic inflammation.

Excess visceral fat is not just stored energy; it actively releases harmful substances that damage your heart, kidneys, and blood vessels. Managing your weight, specifically reducing visceral fat, is a key medical strategy to reduce inflammation and protect your organs.

Chronic Kidney Disease (CKD) significantly amplifies cardiovascular risk, with albuminuria and low GFR being strong predictors of major atherosclerotic and heart failure events, often making CVD the leading cause of death in CKD patients.

If you have kidney disease, your risk of heart problems is significantly higher. Regular monitoring of your heart health, along with managing blood pressure and blood sugar, is essential to prevent heart failure and heart attacks.

High levels of physical activity do not eliminate the increased mortality risk associated with obesity (BMI ≥30); obese active women have nearly double the mortality risk of lean active women.

Do not assume that being physically active makes you immune to the risks of obesity. This study shows that even highly active obese women have nearly twice the risk of death compared to lean, active women. To maximize longevity, you must prioritize both maintaining a healthy weight and staying physically active; exercise alone is not a sufficient shield against the risks of excess adiposity.

ER stress and mitochondrial dysfunction in adipocytes are central mechanisms linking obesity to systemic insulin resistance and inflammation.

Understanding that cellular stress drives disease highlights the importance of reducing the load on adipocytes through weight loss and metabolic health improvements.

Obesity is a disorder of the energy homeostasis system involving the biological defense of an elevated body-fat mass set point, rather than simply the passive accumulation of excess calories.

Understand that your body has a biological 'set point' for body fat that it actively defends. This is why weight loss programs often fail long-term; your body fights back by increasing hunger and decreasing energy expenditure. Effective treatment requires addressing this biological defense, not just relying on willpower or specific diet compositions.

The association between weight gain and breast cancer risk is stronger in women who have never used postmenopausal hormones (PMH) compared to those who have ever used PMH.

For postmenopausal women who have never used hormone therapy, weight gain poses a significantly higher breast cancer risk than for those who have used it. This is because exogenous hormones mask the hormonal effects of body fat.

The risk of cardiovascular disease (myocardial infarction and stroke) is significantly elevated during the prediabetic phase, starting at least 15 years before the clinical diagnosis of type 2 diabetes.

If you have risk factors for diabetes (such as high blood pressure, high cholesterol, or family history), your cardiovascular risk is already elevated, even if you haven't been diagnosed with diabetes yet. Do not wait for a diabetes diagnosis to aggressively manage blood pressure, cholesterol, and lifestyle factors, as the 'clock' for heart disease starts ticking years in advance.

Trans fat consumption remains high globally, with 99.4% of the adult population consuming levels above the optimal limit of 0.5%E.

Actively minimize trans fat intake. Since 99.4% of the global population exceeds optimal levels, prioritize avoiding processed foods containing partially hydrogenated oils. Aim for <0.5% of energy from trans fats.

Type 2 diabetes mellitus in women is associated with a dramatically increased risk of fatal coronary heart disease (CHD) and all-cause mortality, with risk levels comparable to or exceeding those of women with prior CHD but no diabetes.

If you are a woman with type 2 diabetes, your risk of dying from heart disease is extremely high—comparable to a man with diabetes or a woman who has already had a heart attack. You must treat your cardiovascular risk factors (blood pressure, cholesterol, smoking) with the same aggression as someone who has already had cardiac events. Do not assume you are 'low risk' because you haven't had symptoms yet.

The duration of clinical diabetes is monotonically associated with increased risk of fatal CHD, with risk exceeding that of prior CHD alone after 15 years of diabetes duration.

If you have had diabetes for more than 15 years, your risk of fatal heart disease is extremely high, potentially triple that of someone with a prior heart attack if you also have prior CHD. You need aggressive cardiovascular risk management (lipids, BP, lifestyle) regardless of how well you feel. Do not let the passage of time normalize your risk.

Sustained caloric restriction significantly lowers circulating Triiodothyronine (T3) and Thyroid-Stimulating Hormone (TSH) levels, mirroring adaptations seen in long-lived animal models.

Caloric restriction lowers thyroid hormone levels (T3 and TSH) within the normal range. This is a known adaptation to energy deficit and is associated with longevity in animal studies, though its direct causal link to human lifespan is not yet established.

Higher circulating and tissue levels of arachidonic acid (AA) are not associated with an increased risk of cardiovascular disease, and may be associated with a lower risk of total CVD.

You do not need to worry about high levels of arachidonic acid (AA) in your blood as a risk factor for heart disease. This study shows that higher AA levels are not associated with increased CVD risk and may even be linked to lower risk.

Acute resistance exercise-induced elevations in endogenous anabolic hormones (testosterone, GH, IGF-1) do not enhance training-induced muscle hypertrophy or strength gains.

You do not need to perform high-volume, short-rest resistance training specifically to 'spike' your testosterone or growth hormone to build muscle. Standard resistance training protocols that focus on mechanical tension and progressive overload are sufficient for hypertrophy and strength gains, regardless of the acute hormonal response. Do not sacrifice recovery or technique in pursuit of a 'pump' or hormonal spike.

Obesity is a risk factor for the incidence of several cancers including endometrial, colorectal, kidney, esophagus, postmenopausal breast, and pancreas.

Maintaining a healthy weight is crucial for preventing several common cancers, including breast (postmenopausal), colorectal, kidney, esophagus, pancreas, and endometrial cancers.

Obesity involves the biological defense of an elevated body fat mass set point, driven by homeostatic mechanisms that resist fat loss through increased hunger and metabolic efficiency.

Understand that your body actively fights against fat loss through biological mechanisms like increased hunger and reduced metabolic rate. This is not a failure of willpower but a physiological response. Effective treatment requires strategies that address these biological defenses, not just caloric restriction.

Roux-en-Y gastric bypass (RYGB) surgery effectively reduces the defended level of body fat mass by altering gut-brain communication, increasing anorexigenic gut peptides, and reducing food reward valuation.

For morbid obesity, Roux-en-Y gastric bypass is the most effective treatment, significantly reducing the body's defended fat mass set point. It works by altering gut hormones and reducing food reward, leading to sustained weight loss.

High blood pressure is the single largest contributor to cardiovascular disease deaths globally, followed by smoking in men and high BMI in women.

Prioritize blood pressure management above all other cardiovascular risk factors, as it causes the most deaths globally. For men, quitting smoking is the next most critical step. For women, maintaining a healthy body weight is the second most important factor after blood pressure.

Physiological adaptations to weight loss, including slowed resting metabolic rate (RMR) and increased hunger hormones, actively defend a higher body weight 'set-point' and promote weight regain.

After you lose weight, your body will fight to get it back by slowing your metabolism and increasing hunger. This is a biological 'set-point' defense, not a lack of willpower. To maintain weight loss, you must accept that you will need to be more vigilant about food intake and exercise than before, as your body is biologically programmed to regain the weight.

Long-term calorie restriction in nonobese adults increases Sex Hormone-Binding Globulin (SHBG) levels in men, while free testosterone levels decrease significantly at 12 months but not at 24 months.

For men, long-term calorie restriction significantly raises SHBG, which is associated with better metabolic health. While free testosterone drops temporarily at 12 months, it returns to levels comparable to controls by 24 months, suggesting the reproductive axis is not permanently suppressed.

Two-year caloric restriction (approx. 25% reduction) in non-obese younger adults causes significant bone mineral density (BMD) loss at osteoporotic fracture sites (lumbar spine, total hip, femoral neck) driven by uncoupled bone turnover (increased resorption, decreased formation).

If you are undertaking long-term caloric restriction for longevity, be aware that it can cause measurable bone loss at the spine and hip, even if you are young and non-obese. This loss is driven by hormonal changes and increased bone turnover. To mitigate this, ensure adequate calcium and Vitamin D intake (as done in this study) and consider resistance training to preserve fat-free mass, which was identified as a key factor in protecting hip BMD.

Long-term calorie restriction (25% reduction for 2 years) in nonobese humans does not reduce serum IGF-1 levels, but significantly increases IGFBP-1 and decreases the IGF-1:IGFBP-1 ratio, thereby reducing bioavailable IGF-1.

If you are practicing long-term calorie restriction to optimize longevity markers, do not expect your total IGF-1 levels to drop significantly unless you also restrict protein. Instead, you will see a beneficial reduction in bioavailable (free) IGF-1 due to increased IGFBP-1. This suggests that the mechanism of action for CR in humans may differ from rodents, relying more on binding proteins than total hormone suppression.

Long-term calorie restriction in nonobese humans does not produce a sustained increase in serum cortisol, unlike the sustained increase seen in rodents.

Do not worry that long-term calorie restriction will keep your cortisol chronically high. In nonobese individuals, any increase in cortisol is mild and transient, disappearing after the first year. This contrasts with rodent studies where cortisol increases are sustained.

Intensive glucose control (targeting HbA1c <6.0-6.5%) in Type 2 Diabetes does not significantly reduce cardiovascular events and may increase mortality, whereas intensive control in Type 1 Diabetes shows a sustained legacy benefit on CV outcomes.

Do not assume that achieving very low HbA1c levels (e.g., <6.0%) will prevent heart attacks in Type 2 Diabetes. In fact, aggressive control can be dangerous. Prioritize blood pressure and cholesterol management for cardiovascular protection.

Brown adipose tissue generates heat through uncoupling protein 1 (UCP1), which dissipates energy as heat rather than producing ATP, thereby increasing energy expenditure.

Understanding how brown fat works helps explain why some people might burn more calories at rest, but it does not currently offer a practical intervention for weight loss.